Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Last updated about 10 hours ago
about 10 hours ago
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of...
about 10 hours ago
Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation...
about 10 hours ago
Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Date of authorisation...
about 10 hours ago
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Date of authorisation...
about 10 hours ago
Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation...
about 11 hours ago
Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Date of authorisation...
about 11 hours ago
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation...
about 12 hours ago
Orphan designation: chenodeoxycholic acid Treatment of inborn errors in primary bile acid...
about 11 hours ago
Orphan designation: Icerguastat acetate Treatment of amyotrophic lateral sclerosis, 16/05/2022 Positive
about 11 hours ago
Orphan designation: 2-(2-Chlorobenzylidene)hydrazinecarboximidamide acetate Treatment of Charcot-Marie-Tooth disease, 14/12/2015 Positive
about 11 hours ago
Orphan designation: human anti-promyostatin monoclonal antibody (apitegromab) Treatment of spinal muscular atrophy...
about 11 hours ago
Human medicines European public assessment report (EPAR): Rystiggo, rozanolixizumab, Date of authorisation...